Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

ZLAB

Zai Lab Ltd

Pharmaceutical Preparations · SIC 2834CIK 1704292Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$457.0M
Net Income FY2025
$(176.0M)
EPS (Basic, as reported)
$-0.16
Net Margin FY2025
-38.4%
ROE FY2025
-24.5%
Total Equity
$716.0M
Shares Out
89M
Business description

Zai Lab Ltd — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2015–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 0 → 457
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue——01349144213267398457
Cost of revenue——0(4)(17)(52)(74)(96)(147)(191)
Gross profit——0———————
Research & development(32)(39)(120)(142)(223)(573)(286)(266)(235)(221)
Selling, general & administrative(6)(12)(22)(70)(111)(219)(259)(282)(299)(278)
General & administrative(6)(12)————————
Operating income(39)(51)(142)(203)(302)(700)(404)(367)(282)(229)
Interest expense——000000(2)(5)
Interest & investment income01385215403733
Other income (expense), net—10129(6)3754
Pre-tax income(38)(50)(139)(195)(269)(704)(443)(335)(257)(178)
Income tax expense—00000000(3)
Net income(38)(50)(139)(195)(269)(704)(443)(335)(257)(176)
EPS — basic————($0.35)($0.76)($0.46)($0.35)($0.26)($0.16)
EPS — diluted————($0.35)($0.76)($0.46)($0.35)($0.26)($0.16)
Shares outstanding — basic (M)————7779309589669891,095
Shares outstanding — diluted (M)————7779309589669891,095

Showing the latest 10 of 11 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.